SCHEMBL2263287

SCHEMBL2263287

CCOC(=O)/C=C/c1ccc(CN2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 7/20 0.62
KCNH2 Q12809 5/20 0.62
MAPT P10636 2/20 0.48
ALDH1A1 P00352 1/20 0.48
XBP1 P17861 1/20 0.48
HTT P42858 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HPGD P15428 1/20 0.46
DPP4 P27487 3/20 0.45
ALOX15 P16050 1/20 0.45
BRD4 O60885 4/20 0.44
TP53 P04637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12368172 1.00 AR (0.62) ARKCNH2MAPTALDH1A1XBP1
SCHEMBL3165102 0.88 AR (0.68) ARKCNH2MAPTALDH1A1XBP1
SCHEMBL2264942 0.81 AR (0.64) ARKCNH2MAPTALDH1A1XBP1
SCHEMBL2263275 0.81 AR (0.81) ARKCNH2MAPTALDH1A1XBP1
SCHEMBL2265255 0.80 AR (0.74) ARKCNH2MAPTALDH1A1XBP1
SCHEMBL2267323 0.79 AR (0.70) ARKCNH2MAPTALDH1A1XBP1
SCHEMBL2270821 0.79 AR (0.78) ARKCNH2MAPTALDH1A1XBP1
SCHEMBL2266723 0.78 AR (0.77) ARKCNH2MAPTALDH1A1XBP1
SCHEMBL2266886 0.78 AR (0.70) ARKCNH2MAPTALDH1A1XBP1
SCHEMBL2264907 0.78 AR (0.70) ARKCNH2MAPTALDH1A1XBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003649-B2 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155 ASTRAZENECA AB (SE) 2011-08-23 US disclosed
WO-2009081197-A1 BICYCLIC DERIVATIVES FOR USE IN THE TREATMENT OF ANDROGEN RECEPTOR ASSOCIATED CONDITIONS ASTRAZENECA AB (SE) 2009-07-02 WO disclosed